AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2015
Jul 1, 2015
34975_dirs_2015-07-01_5346b3e7-738b-486d-b13b-2b467c2a447f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2015-06-30
Reporting Person: Duchemin Jeffrey (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-30 | Common Stock | J | 2276 | $4.67 | Acquired | 76462 | Direct |
Footnotes
F1: Represents shares acquired under the Issuer's Employee Stock Purchase Plan.
F2: Represents the purchase price for each share purchased under the Employee Stock Purchase Plan and equals 85% of the fair market value of the common stock on January 1, 2015, being the offering date under the plan.
F3: Includes (a) a deferred stock award of 68,900 restricted stock units which shall vest in four equal installments on January 1, 2016, 2017, 2018 and 2019; and (b) 7,562 shares of common stock held by the Reporting Person.